Mechanisms of Vascular Disease 2020
DOI: 10.1007/978-3-030-43683-4_6
|View full text |Cite
|
Sign up to set email alerts
|

Vascular Biology of Smooth Muscle Cells and Restenosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 68 publications
0
2
0
Order By: Relevance
“…Women with a history of IRSA are also at greater risk for having a premature coronary event such as coronary arterial disease and restenosis after the affected pregnancy ( Veerbeek et al., 2016 ; Brosens et al., 2017 ; Benagiano et al., 2021 ). A common link between these cardiovascular disorders and IRSA is the dysregulation of vascular smooth muscle cell (VSMC) plasticity ( Whitley and Cartwright, 2010 ; Brosens et al., 2011 ; Low et al., 2019 ; Nankivell et al., 2020 ). In the systemic vasculature, inappropriate VSMC responses to transforming growth factor beta (TGF-β) signaling are implicated in both coronary arterial disease and restenosis ( Suwanabol et al., 2011 ; Low et al., 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Women with a history of IRSA are also at greater risk for having a premature coronary event such as coronary arterial disease and restenosis after the affected pregnancy ( Veerbeek et al., 2016 ; Brosens et al., 2017 ; Benagiano et al., 2021 ). A common link between these cardiovascular disorders and IRSA is the dysregulation of vascular smooth muscle cell (VSMC) plasticity ( Whitley and Cartwright, 2010 ; Brosens et al., 2011 ; Low et al., 2019 ; Nankivell et al., 2020 ). In the systemic vasculature, inappropriate VSMC responses to transforming growth factor beta (TGF-β) signaling are implicated in both coronary arterial disease and restenosis ( Suwanabol et al., 2011 ; Low et al., 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…The main clinical risk after stent insertion, therefore, remains high platelet adhesion and activation, directly connected to stent-thrombosis; at the site of injury, which is common in stenting procedures, platelets quickly adhere and start to form a plug and blood coagulation that leads to vessel occlusion [ 14 ]. Besides, the uncontrolled proliferation of smooth muscle cells with high risk leads to the narrowing of a blood vessel and restricts blood flow [ 15 ]. These conditions can further lead to heart attack and stroke [ 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%